Alprostadil: profile and news

VIVUS to Present at Cowen & Co. 26th Annual Health Care Conference Mar 2, 2006
The company currently markets MUSE(R) (alprostadil) suppository for the treatment of erectile dysfunction in the US and internationally through distributors. ... - PR Newswire (press release),

PEOPLE'S PHARMACY Drug warnings too often ignored Jan 31, 2006
Caverject (alprostadil) injected into the penis is less likely to cause headaches. Q: My wife and I both have cholesterol issues. ... - Houston Chronicle,

Is heartburn medication causing a craving for ice? Jan 31, 2006
Caverject (alprostadil) injected into the penis is less likely to cause headaches. Q. How valid are expiration dates on prescription drugs? ... - SouthCoastToday.com,

ADD drug can upset stomach Jan 29, 2006
...about alternative approaches. Caverject (alprostadil) injected into the penis is less likely to cause headaches. Joe Graedon, a ... - Los Angeles Times,

Ice craving could indicate deficiency Jan 31, 2006
...ask your doctor about alternative approaches. Caverject (alprostadil) injected into the penis is less likely to cause headaches. - Charlotte Observer,

VIVUS Completes Enrollment in Phase 2b Study of ALISTA(TM) for ... Dec 7, 2005
...(NASDAQ: VVUS) today announced it completed enrollment in its Phase 2b clinical study of its investigational drug ALISTA(TM) (topical alprostadil), for the ... - PR Newswire (press release),

Try Caverject to battle erectile dysfunction? Dec 5, 2005
...injections. Caverject contains the prescription drug alprostadil, which usually produces an erection within five to 10 minutes. ... - Charlotte Observer,

VIVUS Announces Presentation of Positive Results From Five Key ... Nov 17, 2005
VIVUS currently markets MUSE® (alprostadil) suppository for the treatment of erectile dysfunction in the US and internationally through distributors. ... - Yahoo! News (press release)

VIVUS to Present at Healthcare Investment Conferences in November 31 Oct 2005
VIVUS currently markets MUSE(R) (alprostadil) suppository for the treatment of erectile dysfunction in the US and internationally through distributors. ... - PR Newswire (press release),

Topical Alprostadil Cream Improves Sexual Arousal in Women with ... Oct 20, 2005
MONTREAL, QC -- October 20, 2005 -- Application of alprostadil cream appears to improve sexual arousal in women with female sexual arousal disorder (FSAD ... - DG News

NexMed Will Make Two Presentations During the Annual Meeting of ... Oct 27, 2005
Femprox(R) is NexMed's proprietary FSAD treatment under development and incorporates alprostadil (PGE1) with the patented NexACT(R) technology. ... - PR Newswire (press release),

NexMed Announces Upcoming Presentations Oct 7, 2005
Title: A randomized, placebo-controlled, double-blind, parallel design study of the efficacy and safety of specially formulated alprostadil topical cream in ... - PR Newswire (press release),

VIVUS Completes Enrollment in Phase 3 Study of Evamist(TM) for ... 11 Oct 2005
VIVUS currently markets MUSE(R) (alprostadil) suppository for the treatment of erectile dysfunction in the US and internationally through distributors. ... - PR Newswire (press release),

Volunteers Needed at Stanford for Study of Sexual Dysfunction Aug 29, 2005
...are looking for volunteers to participate in a multicenter clinical study on the effectiveness of a topical solution containing alprostadil, or prostaglandin E1 ... - Business Wire (press release),

Erectile dysfunction Aug 31, 2005
Alprostadil (al-PROS-tuh-dil) is a synthetic form of the hormone prostaglandin E. This hormone helps relax smooth muscle tissue in the penis, which in turn ... - Health24.com,

VIVUS Reports Second Quarter 2005 Financial Results and Product ... Jul 28, 2005
...announced results of a study in premenopausal women diagnosed with female sexual arousal disorder (FSAD) treated with ALISTA (topical alprostadil) to the ... - Yahoo News (press release)

VIVUS Announces Second Quarter Financial Results Conference Call Jul 25, 2005
VIVUS currently markets MUSE® (alprostadil) suppository in the US and internationally through distributors for the treatment of erectile dysfunction. ... - Yahoo News (press release)

Female arousal - NIH accept clinical study of Zestra(TM) for women Jul 24, 2005
Current prescription drugs under development include topical alprostadil, many delivery systems for testosterone and intranasal melanocortin analog. ... - I-Newswire.com (press release) <**results**>

NexMed Will Make Five Presentations at BIO 2005 Jun 14, 2005
June 21, 2005, 1:00 PM - 4:00 PM Poster Presentation: The Efficacy and Safety Of Alprostadil Cream (Alprox-TD) In Male Patients with Mild to Severe Erectile ... - PR Newswire (press release)

Erectile Drugs, Used With Care, Help Jun 28, 2005
...complicated. One very effective agent, alprostadil, must be administered directly into the urethra or injected into the penis. The ... - The Ledger

Adrenal-gland failure can cause a blood-pressure drop Jun 23, 2005
There are other approaches. Alprostadil injection is an alternate choice. The injection is made into the penis. ... Alprostadil also comes in pellet form. ... - Yuma Sun

VIVUS to Present at 15th Annual Wachovia Securities Nantucket ... Jun 22, 2005
VIVUS currently markets MUSE® (alprostadil) suppository in the US and internationally through distributors for the treatment of erectile dysfunction. ... - Yahoo News (press release)

Efficacy Greater Than 80% Seen in Avanafil Erectile Dysfunction ... Jun 23, 2005
VIVUS currently markets MUSE(R) (alprostadil) suppository in the US and internationally through distributors for the treatment of erectile dysfunction. ... - PharmaLive.com (press release),